Watching Paint Dry
Watching Sangamo's progress is worse than watching paint dry! All these upstarts are racing ahead & SGMO is enrolling 1 patient every month or other month, at this glacial speed when can we expect a phase 3 Hemophilia trial and when will we ever get to the market? I'm beginning to despair that this company will ever get to any finish line. I'm heavily in the red, having been with Sangamo for over 5 years. First company in gene editing, all that promise and now it seems that others will get where we should have been at least 2 years ago!
They were supposed to have enrolled their first patient this month, have they?